share_log

NLS Pharmaceutics Receives Notice Of Allowance For U.S. Patent Titled 'MAZINDOL TREATMENT FOR HEROIN DEPENDENCE AND SUBSTANCE USE DISORDER'

NLS Pharmaceutics Receives Notice Of Allowance For U.S. Patent Titled 'MAZINDOL TREATMENT FOR HEROIN DEPENDENCE AND SUBSTANCE USE DISORDER'

NLS 藥劑學收到美國專利的津貼通知，標題為「馬津多爾治療海洛因依賴和物質使用障礙」
Benzinga Real-time News ·  2022/12/01 01:01

$NLS Pharmaceutics (NLSP.US)$ Receives Notice Of Allowance For U.S. Patent Titled 'MAZINDOL TREATMENT FOR HEROIN DEPENDENCE AND SUBSTANCE USE DISORDER'

$NLS Pharmaceutics (NLSP.US)$收到標題為「MAZINDOL 治療海洛因依賴和物質使用障礙」的美國專利津貼通知

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論